Literature DB >> 11207610

Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria.

B Kenny1, M Jepson.   

Abstract

Many Gram-negative pathogens use a type III secretion apparatus to deliver effector molecules into host cells to subvert cellular processes in favour of the pathogen. Enteropathogenic Escherichia coli (EPEC) uses such a system to deliver the Tir effector molecule into host cells. In this paper, we show that the gene upstream of tir, orf19, encodes an additional type III secreted effector protein. Orf19 is delivered into host cells by a mechanism independent of endocytosis, but dependent on EspB. Orf19 is targeted to host mitochondria, where it appears to interfere with the ability to maintain membrane potential. Although the precise role of Orf19 remains to be elucidated, its interaction with mitochondria suggests a possible role in the subversion of key functions of these organelles, such as energy production or control of cell death. This is the first example of a type III secreted protein targeted to mitochondria; it is probable that homologues (present in EPEC and Shigella species) and other bacterial effectors will also target this organelle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11207610     DOI: 10.1046/j.1462-5822.2000.00082.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  91 in total

1.  Enteropathogenic Escherichia coli (EPEC) Tir receptor molecule does not undergo full modification when introduced into host cells by EPEC-independent mechanisms.

Authors:  B Kenny; J Warawa
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF.

Authors:  Simon J Elliott; Colin B O'Connell; Athanasia Koutsouris; Carl Brinkley; Michael S Donnenberg; Gail Hecht; James B Kaper
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 3.  Virulence of enteropathogenic Escherichia coli, a global pathogen.

Authors:  S C Clarke; R D Haigh; P P E Freestone; P H Williams
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

4.  Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter.

Authors:  Xavier Charpentier; Eric Oswald
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

5.  Transcriptome of enterohemorrhagic Escherichia coli O157 adhering to eukaryotic plasma membranes.

Authors:  Sivan Dahan; Stuart Knutton; Robert K Shaw; Valerie F Crepin; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 6.  Interactions between bacterial pathogens and mitochondrial cell death pathways.

Authors:  Thomas Rudel; Oliver Kepp; Vera Kozjak-Pavlovic
Journal:  Nat Rev Microbiol       Date:  2010-09-06       Impact factor: 60.633

7.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

Review 8.  Mimicking GEFs: a common theme for bacterial pathogens.

Authors:  Robert C Orchard; Neal M Alto
Journal:  Cell Microbiol       Date:  2011-12-01       Impact factor: 3.715

Review 9.  Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy.

Authors:  Pedro Escoll; Sonia Mondino; Monica Rolando; Carmen Buchrieser
Journal:  Nat Rev Microbiol       Date:  2015-11-23       Impact factor: 60.633

10.  The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).

Authors:  Nichollas E Scott; Cristina Giogha; Georgina L Pollock; Catherine L Kennedy; Andrew I Webb; Nicholas A Williamson; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.